" /> Futuximab/Modotuximab Mixture - CISMeF





Preferred Label : Futuximab/Modotuximab Mixture;

NCIt synonyms : Futuximab/Zatuximab; Futuximab/Modotuximab; Anti-EGFR Monoclonal Antibody Mixture Sym004;

NCIt definition : A mixture of two recombinant IgG1 antibodies directed against different epitopes in the epidermal growth factor receptor (EGFR) extracellular domain III, with potential antineoplastic activity. Anti-EGFR monoclonal antibody mixture Sym004 binds to the extracellular domain of EGFR, thereby preventing ligand binding. This may prevent activation and subsequent dimerization of the receptor; the decrease in receptor activation may result in an inhibition of downstream ERK and JNK signaling pathways and thus inhibition of EGFR-dependent tumor cell proliferation and metastasis. In addition, binding of Sym004 to EGFRs causes EGFR internalization and degradation. EGFR, a receptor tyrosine kinase, often is overexpressed on the cell surfaces of various solid tumor cell types.;

Molecule name : Sym004;

NCI Metathesaurus CUI : CL421582;

Details


You can consult :


Nous contacter.
08/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.